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Abstract 
Infection prevention in dentistry is an important topic that has gained more interest in recent 
years and guidelines for the prevention of cross-transmission are common practice in many 
countries. However, little is known about the real risks of cross-transmission, specifically in 
the dental healthcare setting. This paper evaluated the literature to determine the risk of cross-
transmission and infection of viruses and bacteria that are of particular relevance in the dental 
practice environment. Facts from the literature on HSV, VZV, HIV, hepatitis B, C and D 
viruses, Mycobacterium spp., Pseudomonas spp., Legionella spp. and multi-resistant bacteria 
are presented. There is evidence that hepatitis B virus is a real threat for cross-infection in 
dentistry. Data for the transmission of, and infection with, other viruses or bacteria in dental 
practice are scarce. However, a number of cases are probably not acknowledged by patients, 
healthcare workers and authorities. Furthermore, cross-transmission in dentistry is under-
reported in the literature. For the above reasons, the real risks of cross-transmission are likely 
to be higher. There is therefore a need for prospective longitudinal research in this area, to 
determine the real risks of cross-infection in dentistry. This will assist the adoption of 
effective hygiene procedures in dental practice. 
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The oral cavity is a natural habitat for a large number of microorganisms. This ecological 
niche can be a reservoir for opportunistic and pathogenic microorganisms that can pose a risk 
for cross-contamination and infection and may even cause systemic infections. This is of 
particular importance in the case of routine dental practice, as the risk of exposure to 
microorganisms in the oral cavity is increased due to the open and invasive nature of the 
procedures. 
 It is important to consider that the pathways of contamination can be bidirectional. An 
infectious microorganism may be transferred from the patient to members of the dental team, 
but also vice versa, for example through the hands of the dental team. Moreover, another 
infectious association is the transfer of pathogens from patient to patient, without the 
mediation of the dental staff, but rather through a surface located in the dental practice, or a 
device or instrument used during dental procedures. This can apply in the case of inadequate 
sterilization of the dental instruments or disinfection of the dental unit. The possibility also 
exists that pathogens present in dental unit waterlines (DUWLs) could be spread by aerosols 
created by dental hand-pieces, presenting a risk for both the patient and members of the 
dental team. 
There are a number of possible means by which transmission of viral and bacterial 
pathogens can occur in the dental practice. The patient’s own saliva and blood are major 
vectors of cross-transmission. Blood-borne contamination can occur by exposure to the 
infectious material through non-intact skin and mucosal lesions. The highest infectious risk of 
this type is associated with accidental punctures by contaminated needles or injuries by sharp 
instruments. Insufficient cross-contamination control, such as improperly sterilized dental 
instruments, is also a possible device-borne means of pathogen transmission. Emanation of 
the pathogens through the spray of the hand-pieces of the dental unit can also be considered 
an air-borne or water-borne means of transmission, which may affect both the patient and the 
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dental team. Air-borne infections can also occur via an inefficient ventilation system in the 
dental practice environment, whereby contaminated air may be withheld or recycled. Overall, 
the risk of any such transmission depends on the dose of the pathogens transmitted, the 
virulence of the pathogen, as well as the frequency or probability of exposure to the 
infectious material and the state of the host immune responses  
The aim of this position paper on healthcare-associated infections in dentistry was 
primarily to evaluate cross-transmission risks of relevant viral and bacterial infections based 
on the evidence available in the current literature.  
 
Viruses   
Herpes viruses 
Herpes viruses are ubiquitous human pathogens which can all be found in the oral 
environment. Cross-transmission risks in dentistry are mainly related to herpes simplex virus 
type 1 (HSV-1) and type 2 (HSV-2) and to varicella-zoster virus (VZV). Oral secreta can also 
be infectious in the sub-clinical phase of herpes virus infections and constitute a risk of cross-
transmission. 
 
Herpes simplex virus (HSV) 
In Europe, the age standardized seropositivity for HSV-1 ranges from 52% in Finland to 84% 
in Bulgaria and the Czech republic. For HSV-2 the seroprevalence ranges from 4% in 
England and Wales to 24% in Bulgaria [1]. Seropositivity increases with age. In the U.S. on 
average 60.3% of the population is infected with HSV-1 [2]. The seroprevalence of HSV-1 is 
92% and of HSV-2 is 13.2% in rural parts of East China [3]. 20-40% of the seropositive 
subjects have recurrent infections in the oral region and asymptomatic shedding is common 
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[4]. Manipulation of the oral region, endotracheal intubation and immune-suppression are 
health or medical care -associated factors known to provoke oral reactivation of HSV-1 [5, 
6]. Previously, HSV-1 primary infections were commonly acquired in childhood. According 
to recent literature, however, a large proportion of young adults in Western countries today 
are not infected with HSV -1 [1]. 
HSV is highly contagious and is transmitted via exposure of the mucosa or skin to 
infectious secreta or contents of an infectious HSV blister.  In the periphery, HSV-1 is most 
commonly associated with mucosal infections of the oral region and HSV-2 with genital 
infections, although both viruses are detected in either anatomical region. In the oral region, 
HSV-1 primary infection causes gingivostomatitis in 1-10% of patients and labial herpes or 
intraoral herpetic ulcers are typical symptoms of reactivation [7]. 
Unless adequate personal protection is worn, the dental team and the patient are at 
risk of being exposed to HSV via direct contact with herpetic ulcers or infectious splatters 
from herpetic lesions or saliva [8]. This could result in mucosal or skin infections, keratitis or 
herpetic whitlow. Outside the body HSV is inactivated within hours and is easily inactivated 
by disinfectants, such as alcohols. 
There are only a few reports of HSV cross-infection in the dental practice. The 
frequency of herpetic whitlow was observed to be higher among practicing dentists compared 
to the normal population [9]. However, reports confirming the transmission of infection from 
the patient to the dental team infection are available in the literature [8]. Also the cross-
infection of HSV from dental team to patients has been shown. A dental hygienist with a 
herpetic whitlow, who did not use gloves routinely, infected 20 out of 46 patients [10].  
A large portion of the adult population is infected with HSV-1 and reactivations 
resulting in subclinical or symptomatic infection are frequent. However, little research is 
published on the cross-transmission and infection of HSV-1 through the dental practice. 
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Varicella-zoster virus (VZV) 
Chickenpox is the manifestation of VZV primary infection. About 90% of unvaccinated 
children acquire chickenpox before school age [11]. In the periphery, VZV reactivation 
typically manifests as zoster of the skin or mucosa affecting 1-3 dermatomes in an episode. 
20-30% of people are estimated to have zoster during lifetime [12]. VZV can be also 
asymptomatically shed in saliva. Immune suppressed patients are at increased risk for 
disseminated disease and in non-immune pregnant women fetal infections are possible.   
 VZV is a highly contagious virus. It is transmitted through direct contact to the 
blisters or exposure to infectious droplets from saliva or the respiratory system. Airborne 
transmission is also possible [13]. 
Cross-transmission during dental care has not been reported, but VZV is known to 
cause healthcare-associated infections. After inadvertent exposure in the hospital 
environment, the transmission rate has been reported to be 4.5-29% [14]. Respiratory secreta 
can already be contagious 2-4 days before varicella rash eruption. In addition to rashes, 
secreta of a zoster patient may also be contagious  [15].  VZV DNA has been detected in the 
environmental contact area of a zoster patient but also in the air-conditioner filter in a zoster 
patient’s room, indicating a possibility of spread by aerosols from zoster patients [15, 16]. 
There is no evidence of VZV cross-transmission within dental healthcare but reports 
from other medical fields indicate that VZV infection constitutes a risk for healthcare-
associated transmission of VZV in the dental practice as well. 
 
Human Immunodeficiency Virus (HIV) 
In the 2010 UNAIDS report the total number of people infected with HIV worldwide in 2009 
was estimated to be 33.3 million (0.8% of the global population). The HIV prevalence ranges 
from 0.2% in Central and Western Europe to 5% in Sub-Saharan Africa.  
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In prospective studies the risk of HIV infection after the percutaneous exposure to 
HIV infected blood was estimated to be 0.3% [17, 18]. After mucous membrane exposure the 
risk is approximately 0.09% [19]. The risk of acquiring HIV after exposure to tissues or other 
body fluids of an HIV infected person is not quantified, but is thought to be substantially 
lower [18]. The risk of an infection correlates with the volume of blood exposure and blood 
viral counts  [20]. Transmission of HIV via saliva is considered unlikely due to low salivary 
viral titers, low numbers of CD4-positive target cells and the presence of anti-HIV antibodies 
and salivary antiviral factors protecting oral tissues [21].  
Until December 2002, there were 344 published cases worldwide in which healthcare 
workers were infected with HIV as a result of their profession [22]. Of these, 106 were 
documented to result from occupational exposure. For dental professionals 8 possible 
occupationally acquired HIV infections were published, although no cases were confirmed 
[22]. In four cases transmission of HIV from a healthcare worker to a patient was reported; a 
dentist in Florida, USA [23], a nurse in France [24], an orthopedic surgeon in France [25] and 
an obstetrician in Spain [26]. Transmission of HIV from patient to patient has been reported, 
particularly as a result of poor infection control in developing countries and in developed 
countries in recipients of blood and blood products [27]. There are no reports of patient to 
patient transmission of HIV in the dental practice.  
The risk of transmission of HIV through the dental practice appears to be low, 
however the data may not provide the complete picture. For instance, no occupationally 
acquired HIV infections were reported in Asia or parts of Africa and South-America, yet the 
prevalence of HIV in some of these areas is high [28]. Given that the risk of exposure to HIV 
is expected to be higher in areas where the prevalence of HIV infection is high, one would 
have anticipated reported cases of healthcare associated HIV transmission from these areas 
too. 
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Hepatitis B virus 
The prevalence of chronic hepatitis B virus (HBV) infections (positive for surface antigen 
HBsAg ) ranges from <2% in Europe and the USA to 8% in Asia. However, the prevalence 
of people that have experienced an HBV infection at some stage (positive for antibodies to 
HBc) ranges from 4-15% in low endemic countries to 40-90% in high endemic countries 
[29].  
Before HBV vaccination was available, HBV infection was considered to be an 
occupational risk for healthcare workers and laboratory personnel [30]. Following the 
introduction of the vaccine in 1983, the percentage of dentists with serological evidence of an 
HBV infection declined, especially in young dentists [31]. However, even after the vaccine 
became available, healthcare providers remained at risk for HBV infection [32]. The risk of 
an infection with HBV highly depends on the volume of blood and on the hepatitis B e 
antigen (HBeAg) status of the source [33]. The risk of HBV transmission to a healthcare 
worker after the percutaneous exposure to HBeAg- and HBsAg-positive blood is 
approximately 30%. The risk of HBV transmission after the percutaneous exposure to 
HBsAg-positive, HBeAg-negative blood is 1-6% [34]. Besides through percutaneous injuries, 
HBV infection can also result from (in)direct blood or body fluid exposure through 
inoculation into cutaneous scratches, abrasions, burns or on mucosal surfaces [35]. HBV has 
demonstrated the ability to survive and remain infectious in dried blood at room temperature 
on environmental surfaces for at least one week and probably longer [36]. 
The US Centers for Disease Control (CDC) described 300 patients that were infected 
through HBV-infected healthcare workers, including dentists and oral surgeons [34]. Perry et 
al. [37] reported that a total of 12 healthcare workers had infected 91 patients with HBV 
between 1991 and 2005. The percentage of patients infected by the healthcare workers was 
2.96%. None of the healthcare workers were dentists or members of the dental team. 
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Recently, patient-to-patient transmission of HBV in an oral surgery practice was 
demonstrated using molecular techniques [38]. In this case an older woman that had oral 
surgery contracted an acute hepatitis B virus infection 2 months after her visit to the oral 
surgeon. The source turned out to be a woman that had oral surgery on the same date, in the 
same room, with the same hospital staff, 2 hours before the index patient. Other patients that 
were treated on the same day and the hospital staff that worked on that day were not infected. 
Interestingly, the CDC did not find breaches in standard infection control practices [38]. 
Vaccination of healthcare workers for HBV has greatly reduced the risk of 
transmission of HBV. However, HBV is highly infectious and vaccination for HBV is not 
standard for healthcare workers throughout the world. Moreover, patient-to-patient 
transmission of HBV has recently been proven. The risk of transmission of HBV through the 
dental practice remains an issue. 
 
Hepatitis C virus 
The prevalence of Hepatitis C virus (HCV) infection ranges from 0.1-1% in Northern Europe, 
0.2-1.2% in Central Europe and 2.5-3.5% in Southern Europe [39]. However, the prevalence 
of HCV infection can be as high as 26% in the southern parts of Italy [40]. In the Eastern part 
of Europe the prevalence of HCV infection was reported to be 0.9-4.9% of blood donors and 
1 – 10% of health care workers [41]. High prevalence of HCV outside of Europe is found in 
Egypt (14.9%), Taiwan (4.4%), Vietnam (2-2.9%) and Pakistan (3%) [42]. Here the regional 
differences are large as well. The prevalence rate of HCV is 30% in the Punjab region in 
Pakistan. 
Relatively little is known about the occupational risk of HCV infection. The average 
transmission rate of HCV after exposure is about 0.5% [43], much lower than for HBV and 
slightly higher than for HIV. The risk of transmission of HCV was significantly associated 
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with hollow-bore needle placement in the source patient’s artery or vein, deep injury and the 
sex of the healthcare worker. All cases of HCV transmission occurred after percutaneous 
exposure to viraemic blood or body fluids and the risk of transmission increased with the 
HCV viral load [44]. 
Perry et al. [37] reported a total of 11 HCV-positive healthcare workers that infected 
38 patients between 1991 and 2005. The HCV-infected healthcare workers did not include 
dentists or oral surgeons. One study [45] assessed the risk of HCV infection among dentists 
in New York. Dentists and especially oral surgeons were at higher risk of having anti-HCV 
antibodies in their blood than matched blood donors. The higher risk for HCV infection was 
only attributed to occupational exposure. In the Netherlands, two cases of Hepatitis C virus 
infection resulting from blood exposure accidents have been documented in health care 
workers [46, 47]. Occasionally, cases of acute HCV infection are attributed to blood exposure 
accidents. In a UK dental practice 1.2% of the staff  (none of the dentists) were positive for 
HCV antibodies.  Since the prevalence of HCV in the British population is 0.08 – 0.55%, the 
dental healthcare workers have a slightly higher risk of HCV infection compared to the 
general population [48].  
In the general population the prevalence of HCV-infected patients is relatively low. In 
combination with a low average transmission rate, the risk of HCV transmission in the dental 
practice appears to be low. Research seems to support this conclusion. However, little is 
known about the transmission of HCV in comparison to HBV and HIV. Vaccination for HBV 
does not protect against infection with HCV. 
 
Hepatitis D virus 
Hepatitis D virus (HDV) infection can only occur in patients that are HBV co-infected. The 
incidence of hepatitis D virus infection is not known, but is thought to be at about 5% of  
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HBV carriers. In the literature, there are a lack of available reports regarding HDV infections 
in dentistry. One paper reported an outbreak of HDV in the 1980’s where dentists were 
involved [49].  
 
Bacteria  
Viruses are mainly associated with a specific disease whilst for many bacteria this is not the 
case. Often transmission of bacteria does not result in a real infection, especially when 
opportunistic bacteria are involved. In the following sections, some severe pathogens are 
discussed that are potentially transmitted in the dental office. Furthermore, special forms of 
commensal bacteria that are (multi)-resistant to antibiotics are discussed, since they can result 
in severe and even lethal infections.  
 
Mycobacterium ssp.  
Mycobacterium tuberculosis causes the disease tuberculosis (TB). Other Mycobacterium spp. 
such as M. bovis are also capable of causing the disease. TB continues to be a major health 
burden in the 21st century with an estimated 1.7 million deaths every year [50]. In the UK the 
number of reported cases of TB have been rising in recent years [51]. Furthermore, the 
emergence of multi-drug resistant strains of M. tuberculosis (MDR-TB) is a major problem in 
the successful treatment and control of TB [52]. Transmission of M. tuberculosis occurs 
through aerosols generated by coughing, sneezing and speaking. M. tuberculosis can remain 
airborne within small droplets for several hours and susceptible individuals can still become 
infected [52]. It is thought that as few as 1-5 bacilli are required to initiate infection [53].Only 
about 30% of those exposed to TB are infected, 90% of them latently. In latent infection the 
bacteria remain viable in the body for many years without causing an active infection but 
retain the ability to activate under favorable conditions. It is not possible to predict who will 
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develop active TB at some point [54]. However, risk factors include immune-compromising 
situations such as chronic inflammatory diseases, during antitumor necrosis factor therapy, 
diabetes/obesity or a HIV co-infection [55]. Other risk factors include alcoholism, and poor 
nutrition [54]. 
The possibility of M. tuberculosis transmission within dental settings has been subject 
to risk assessments by the CDC. Most dental clinics in the US were considered to fall within 
a very low risk category [56, 57]. Despite the putative low risk, evidence for the transmission 
of TB in dental practice is present. In the UK a report documented cases of intraoral and 
pulmonary TB in patients that had been infected by their dental surgeon [58]. All of the 
patients had tooth extractions performed by the dental surgeon who had active pulmonary 
TB. Furthermore, dental team-to-dental team and possibly patient-to dental team TB infection 
was documented [59, 60]. Hospital dental staff may be at increased risk of exposure to TB 
[60, 61]. 
The risk of TB transmission in the dental practice appears to be low. However, 
transmission of TB remains possible, primarily through patients from high risk areas in the 
world or from patients with reactivated TB infections such as the present-day elderly who 
may have been exposed to TB in their youth. 
 
 
Pseudomonas spp. 
The opportunistic pathogen Pseudomonas aeruginosa is frequently recovered from DUWLs 
where it can form biofilms in the tubing. Pseudomonas spp. may pose an important health 
hazard, particularly for immune-compromised patients. P. aeruginosa is associated with 
many types of infection, including hospital-acquired pneumonia [62], skin infections [63], 
urinary tract infections [64], burns [65] , eye infections [66] and blood stream infections [67]. 
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Furthermore, P. aeruginosa is increasingly becoming multi-drug resistant, thus negatively 
affecting patient outcomes [68].  
P. aeruginosa was isolated in 25% of studied DUWLs in Canada [69] and in 8% of 
DUWLs in Switzerland, where the dental chair units older than five years were contaminated 
significantly more often than new units [70]. Patients with cystic fibrosis, known to be 
exceptionally susceptible to Pseudomonas spp. infections, were investigated for the presence 
of P. aeruginosa after a dental visit. P. aeruginosa was isolated from up to 5% of DUWLs, 
but only one patient tested positive in sputum for genotypically matched P. aeruginosa [71]. 
Others reported 2 patients with solid tumours that developed gingival abscesses with pyocin-
matched P. aeruginosa after dental treatment. Furthermore, 78 subjects with no underlying 
medical condition were transiently colonized for 3-5 weeks with P. aeruginosa when treated 
in a unit with contaminated water [72].  
Given that the incidence of Pseudomonas spp. in DUWLs is high but that there are 
limited reported cases of infection following exposure to DUWLs, it is apparent that the risk 
of infection is very low. Although reports in this area are conflicting [73, 74]; DUWL 
endotoxin from gram-negative bacteria such as Pseudomonas spp., has been suggested to 
complicate the healing processes after periodontal surgery operations [75] and to induce 
asthma exacerbations [74].  Therefore, further studies will be needed to verify this potential 
health hazard.  
 
Legionella spp. 
Legionella spp. can cause a severe form of pneumonia in humans: Legionnaires’ disease, and 
a less severe flu-like disease: Pontiac fever. Legionella pneumophila, particularly L. 
pneumophila serogroup 1, is the most common etiological agent of Legionnaires’ disease 
although other species of the Legionella genus can also be causal [76]. Inhalation of aerosols 
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contaminated with Legionella spp. acts as the main route of transmission [77]. Legionnaires’ 
disease outbreaks have frequently been associated with contaminated aerosol-producing 
water systems such as showers, humidifiers and water-cooling towers. Legionella spp. can 
readily multiply in water at temperatures between 25-45°C [78], especially in stagnant water 
and they grow in biofilms. Legionnaires’ disease is considered to be an important nosocomial 
infection, about 11.5% of reported Legionnaires’ disease cases in the UK between 1980 and 
2009 were hospital-acquired (UK’s Health Protection Agency Jan 2011). Outbreaks of 
Legionnaires’ disease in hospitals have been predominantly associated with contaminated 
potable water supplies [79]. 
Legionella spp. present a potential risk in the dental clinic where contaminated 
DUWLs could act as a source of infection to both dental staff and patients. DUWLs harbor 
microbial biofilms that are seeded by the mains water supply and can provide a suitable 
environment for the multiplication of Legionella spp. within protozoa [80]. Studies of 
contamination of DUWLs frequently detected Legionella spp. among the bacteria present, 
although their prevalence varies substantially between different studies [81-84]. In particular, 
prevalence rates vary with differing geographic location [80]. While the prevalence of 
Legionella spp. in UK DUWLs varies between 0.37-1.19%, similar studies in the US show 
prevalence rates of 68% [83, 85], although differences in methodology could be responsible 
for these differences. The number of colony forming units (CFU’s) of Legionella spp. found 
in DUWLs has been reported to be around 102-105 CFU/ml. The infective dose of Legionella 
spp. is thought to be greater than 105 CFU/ml [86].  
Very recently a case was published of a patient that was infected with L. pneumophila 
serogroup 1 originating from a dental office in Italy [87]. After hospitalization because of the 
pulmonary problems, the patient died from this infection. By using molecular typing 
methods, it was clearly shown that the source of the Legionella infection was the DUWL in a 
  Healthcare associated infections in dentistry 
 
16 
 
dental practice, where both the tap water and the unit water were contaminated. It is 
remarkable that only one patient acquired this Legionella. Even Pontiac fever was not found 
within the other patients in this office. This is the first time that Legionnaires’ disease 
resulting from visits to, or treatment in, a dental clinic was documented. To date, there are no 
known cases of Pontiac fever in patients, resulting from visits to, or treatment in, a dental 
clinic. This would indicate that the risk to patients posed by Legionella spp. from DUWLs is 
low. However the risk is not absent and infection can have dramatic consequences. In 
addition, cases of Pontiac fever that appear one week after a dental visit may not be 
recognized as such and the link between disease and dental treatment is not acknowledged.  
There is a single documented fatal case of Legionnaire’s disease in a US dentist. In 
this case the infection was attributed to exposure of the dentist to DUWL aerosols containing 
Legionella spp. [81]. L. pneumophilia and L. longbeachae were detected in the dentist’s lung 
tissue and in the DUWLs, however the dentist’s domestic water supplies also had very low 
levels of Legionella spp. The evidence in this case was not conclusive. Studies have found 
dental staff to have higher serum levels of antibodies specific to Legionella spp. than 
members of the general public [88, 89]. This is indicative of an increased occupational 
exposure to Legionella spp. through contaminated aerosols.  
Despite this, no other cases of Legionnaires’ disease or Pontiac fever shown to result 
from occupational exposure have been documented in dental staff. However, the lack of 
investigation into the DUWLs of the dental clinics in other cases of Legionnaire’s disease or 
Pontiac fever in dental staff could have led to under-reporting. 
 
Multi-resistant bacteria 
Multi-resistant bacteria pose a major health risk and are increasing the cost of healthcare 
worldwide [90].  Multi-resistant bacteria are mainly transmitted by direct contact or indirectly 
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via contaminated surfaces. Increased risk of colonization by multi-resistant bacteria is 
associated with long hospital stays, living in a nursing home, institutional and international 
patient transfers, surgical procedures and the presence of invasive devices, severe medical 
conditions, immune suppression and antimicrobial therapy [91, 92].  Currently, the most 
problematic healthcare-associated multi-resistant species are methicillin-resistant 
Staphylococcus aureus (MRSA), extended-spectrum β-lactamase (ESBL) –producing 
Enterobacteriaceae and carbapenemase-producing gram-negative bacteria [93]. 
S. aureus asymptomatically colonizes the oropharynx or the skin of 20-30% of people 
and it has been isolated from various oral infections [94]. S aureus is a commensal bacterium, 
but is also responsible for skin infections, septicaemia, endocarditis, osteomyelitis, 
pneumonia and toxic shock syndrome [95]. Among hospitalized patients receiving treatment 
for oral conditions, oral cancer patients have been reported to be at increased risk for MRSA 
colonization [96-98]. Carriage rate is influenced by the age and the overall disease status of 
the host [99]. MRSA is resistant to all β-lactam antibiotics including methicillin, cloxacillin, 
dicloxacillin, cephalosporins and carbapenems and may also display resistance to some other 
antibiotics. 
During the past ten years, community-acquired MRSA (CA-MRSA) infections have 
been increasing [100]. Studies on the oral or nasopharyngeal MRSA colonization rate report a 
prevalence of up to 26%, depending on the population [101]. In a recent literature review, 
MRSA carriage in healthcare workers was found to be 4.6%, which is above the rate of the 
normal population [102]. In most studies, MRSA carriage in dental healthcare workers has 
not been above the level of the normal adult population [101]. In the greater Houston 
metropolitan area 4.2% of dentists and 1.5% of dental hygienists were positive for MRSA 
[103] whereas only 1.5% of the non-institutionalized US citizens are colonized with MRSA 
[104]. Others showed that 21% of dental students were found to be carrying MRSA in their 
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nose [105]. MRSA carriage in dental staff could pose a risk for transmission of MRSA to the 
patients or co-workers. In the UK, a dentist carrying MRSA was proven to have transmitted 
MRSA to two patients having oral surgery [106]. During one year of surveillance in a dental 
hospital clinic, 8 (out of 140) patients were colonized or infected with MRSA after treatment. 
The air-water syringe and the chair arm of the dental chair were contaminated with MRSA. 
The antibiograms revealed that the isolated MRSA strains were similar between patients and 
the contaminated chair and it was concluded that the patients were colonized or infected by 
(parts of) the dental chair. [107]. Furthermore, MRSA has been isolated in dental clinics 
outside of the hospital environment [108]. Moreover, devices such as dental impression guns 
were reported to be contaminated with MRSA in routine use [109]. Dental impressions and 
gypsum casts were also shown to be heavily colonized by MRSA [110]. 
Multi-resistant gram-negative Enterobacteriaceae can produce the enzyme extended-
spectrum β-lactamases (ESBL) making them multi-resistant to penicillins, second and third 
generation cephalosporins and monobactams [111]. 
Carbapenemase-producing gram-negative bacteria such as Klebsiella pneumoniae 
carbapenemase  (KPC) are the most recent and serious threat of healthcare-associated 
infections since they are resistant to all beta-lactam antibiotics and they display co-resistance 
to other antibiotics. They have spread particularly via international hospital transfers from 
epidemic areas. In addition, Enterobacteriaceae harbouring New Delhi metallo-β-lactamase-
1 (NDM-1) have been repeatedly introduced in Europe via patient transfers [92].  
In healthy individuals oral colonization by Enterobacteriaceae or Pseudomonas spp. 
is usually transient [112]. Even transiently colonizing bacteria can be part of the flora of oral 
cavity related abscesses and source of cross-transmission [113]. ESBL-producers were 
detected in oropharyngeal samples of 40% of the inhabitants in an Italian long-term-care 
facility [114] and in the throat of patients in intensive care units [115, 116].  There are no 
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published reports available on the possible association of ESBL- or carbapenemase-producers 
and oral infections nor evidence for transmission of these bacteria through the dental practice.  
Hence, MRSA has been shown to be transmitted in dental care. However, evidence 
for the transmission of ESBL- and carbapenemase-producers does not exist yet, although 
transmission in the dental practice is possible. 
 
General considerations and concluding remarks 
 This paper aimed to report and discuss the current literature on the transmission of relevant 
viruses and bacteria in dentistry. All viruses and bacteria discussed above can be, and most 
have been, proven to be transmitted to the patient or the dental team in the dental practice. It 
appears that the transmission of, and infection with, hepatitis B virus poses the greatest risk 
for both patients and the dental team, based on the incidence and risk of transmission. 
Literature on the transmission of the other bacteria and viruses is scarce and it seems that the 
risk for transmission resulting in an infection with these microorganisms is low. It should be 
noted, however, that transmission of pathogens may result in an asymptomatic infection that 
can last weeks or even months until symptoms appear (Table 1). In addition, it is likely that 
some patients that visit the dental practice are not aware of their infectious status and may 
carry a latent asymptomatic infection. There is a lack of prospective longitudinal studies that 
investigate the incidence of healthcare-associated infections in patients after dental treatment. 
Another important point to keep in mind is that the likelihood of healthcare-associated 
infections, particularly in dentistry, of being detected, reported, documented and published is 
small [37]. Therefore, healthcare-associated infections are under-reported in literature from 
the developed world [27, 117]. In developing countries the risk of transmission of several 
microorganisms, for instance the blood borne viruses, is high since a large section of the 
population is infected. However, literature on the subject from these countries is scarce.  
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Based on the number of reported cases, most of which were of blood borne viruses, 
the actual risk for developing an infectious disease through the dental practice appears to be 
low. However, the real transmission rate of the viruses and bacteria that are discussed in this 
paper is probably higher. As long as accurate data are absent, the dental team should be fully 
aware of the risk of dissemination of potentially hazardous microorganisms and ensure that 
efficient cross-infection control procedures are well in place [118]. Every member of the 
team must follow the standard procedures required to prevent the transmission of 
microorganisms.  Besides preventing disease by vaccination, these include hand hygiene, 
personal barrier protection, instrument disinfection and sterilization protocols, surface 
decontamination strategies, approaches to maintain the quality of DUWLs, as well as the 
emergency procedures in case of accidents that would increase the risk of cross-transmission. 
These procedures substantially lower the risk of the transmission of microorganisms. Every 
patient should be treated as potentially infectious. The dental team should be acquainted with 
the biological principles behind these procedures. The cross-infection control regulations 
should undergo regular monitoring and need to be subjected to revision whenever necessary. 
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Table 1 Incubation period of microorganisms associated with healthcare infections in 
dentistry 
 
Microorganism Incubation period 
Herpes simplex virus Up to 2 weeks 
Varicella zoster virus 2-3 weeks 
Hepatitis B/C/D virus Up to 6  months 
HIV/AIDS Months-years 
Mycobacterium tuberculosis Up to 6 months 
Pseudomonas spp. 3-10 days 
Legionella spp. 2-19 days 
Staphylococcus aureus 4-10 days 
 
